Prevalence of inapropriate LDL cholesterol levels in patients with coronary disease and/or type 2 diabetes

被引:26
|
作者
Perez de Isla, L. [1 ]
Saltijeral Cerezo, A. [2 ]
Vitale, G. [3 ]
Gonzalez Timon, B. [3 ]
Torres Do Rego, A. [4 ]
Alvarez-Sala Walther, L. A. [4 ]
机构
[1] Hosp Clin San Carlos, Serv Cardiol, Madrid, Spain
[2] Hosp Tajo, Serv Cardiol, Madrid, Spain
[3] MSD Espana, Dept Med Merck Sharp & Dohme, Madrid, Spain
[4] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Unidad Riesgo Cardiovasc & Lipidos, Inst Invest Sanitarias,Fac Med,Red RECAVA, Madrid, Spain
来源
REVISTA CLINICA ESPANOLA | 2012年 / 212卷 / 10期
关键词
Hypercholesterolaemia; Cardiovascular risk factors; Metabolic syndrome; Cardiovascular risk control; HIGH-DENSITY-LIPOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; RISK-FACTORS; SECONDARY PREVENTION; MORTALITY;
D O I
10.1016/j.rce.2012.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Clinical practice guidelines recommend achieving concentrations of LDL cholesterol less than 100 mg/dl (and in some cases less than 70 mg/dl) in patients with coronary artery disease and/or diabetes mellitus type 2 (DM2). We have examined the compliance with these objectives in patients treated in Spain with these conditions. Methods: Cross-sectional epidemiological study. Data were obtained during the visit of the study or, in their absence, based on data contained in the medical record by 874 doctors of the 17 autonomous communities in Spain. Demographic information, risk factors, cardiovascular and prescribed treatments were collected. Results: In the final analysis 6.988 (62.7% male) patients were included. 2586 (37%) had coronary disease, 2654 (38%) DM2 and 1748 (25%) both conditions. 65% had metabolic syndrome. Vascular risk factors median number was 4. 57% and 86% showed a concentration of LDL cholesterol > 100 and >70 mg/dl respectively. The proportion patients with LDL concentration >100 mg/dl was 4% greater in the DM2 (62.4%) than in coronary patients (57.1%; p 0.0001). Concentration of triglycerides > 150 mg/dl was higher in patients with DM2 (50.5%) than in coronary patients (43.5%; p 0.0001). The proportion of patients with LDL > 70 mg/dl was similar in the coronary group and in the DM2 Group (88.4% and 87.0%, respectively). More than half of patients with coronary heart disease (57.5%) or DM2 (55.7%) showed inadequate levels of HDL (< 40 mg/dl men; <50 mg/dl women). Conclusions: More than a half of patients with diabetes mellitus and/or coronary artery disease enrolled in the CODIMET study do not achieve the recommended LDL cholesterol target for high cardiovascular risk patients. (c) 2012 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:475 / 481
页数:7
相关论文
共 50 条
  • [1] Computational statistical modelling for parameters optimization of LDL-cholesterol levels in patients with type 2 diabetes
    Ahmad, Wan Muhamad Amir W.
    Ghazali, Farah Muna Mohamad
    Bin Shahzad, Hazik
    Adnan, Mohamad Nasarudin
    Aleng, Nor Azlida
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2024, 23 (02): : 498 - 506
  • [2] Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes
    Zoppini, G.
    Targher, G.
    Chonchol, M.
    Perrone, F.
    Lippi, G.
    Muggeo, M.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (08) : 580 - 586
  • [3] Remnant Cholesterol and the Risk of Coronary Artery Disease in Patients With Type 2 Diabetes
    Wang, Kexin
    Ding, Yaodong
    Wang, Rui
    Yang, Jiaxin
    Liu, Xiaoli
    Han, Hongya
    Shen, Hua
    Sun, Yan
    Zhou, Yujie
    Ge, Hailong
    ANGIOLOGY, 2023, 74 (08) : 745 - 753
  • [4] Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes
    Zhao, Zi-Wen
    Lin, Chao-Gui
    Wu, Ling-Zhen
    Luo, Yu-Kun
    Fan, Lin
    Dong, Xian-feng
    Zheng, Hong
    BIOMARKERS, 2013, 18 (02) : 160 - 164
  • [5] LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes
    Eliasson, B.
    Gudbjoernsdottir, S.
    Zethelius, B.
    Eeg-Olofsson, K.
    Cederholm, J.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (11) : 1420 - 1428
  • [6] High Prevalence of Coronary Heart Disease in Type 2 Diabetic Patients with Non-alcoholic Fatty Liver Disease
    Lu, Hongyun
    Zeng, Longyi
    Liang, Biao
    Shu, Xiaochun
    Xie, Danhong
    ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (07) : 571 - 575
  • [7] Serum Level of Triglycerides Is a Potent Risk Factor Comparable to LDL Cholesterol for Coronary Heart Disease in Japanese Patients with Type 2 Diabetes: Subanalysis of the Japan Diabetes Complications Study (JDCS)
    Sone, Hirohito
    Tanaka, Sachiko
    Tanaka, Shiro
    Iimuro, Satoshi
    Oida, Koji
    Yamasaki, Yoshimitsu
    Oikawa, Shinichi
    Ishibashi, Shun
    Katayama, Shigehiro
    Ohashi, Yasuo
    Akanuma, Yasuo
    Yamada, Nobuhiro
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (11) : 3448 - 3456
  • [8] Nonlinear relation between pulse pressure and coronary heart disease in patients with type 2 diabetes or hypertension
    Nargesi, Arash A.
    Esteghamati, Sadaf
    Heidari, Behnam
    Hafezi-Nejad, Nima
    Sheikhbahaei, Sara
    Pajouhi, Atieh
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    JOURNAL OF HYPERTENSION, 2016, 34 (05) : 974 - 980
  • [9] Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes
    Trojak, Aleksandra
    Walus-Miarka, Malgorzata
    Wozniakiewicz, Ewa
    Malecki, Maciej T.
    Idzior-Walus, Barbara
    MEDICAL SCIENCE MONITOR, 2013, 19 : 1167 - 1172
  • [10] Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol
    Hirano, Tsutomu
    Kodera, Rieko
    Hirashima, Takeshi
    Suzuki, Natsuko
    Aoki, Ema
    Hosoya, Mitsuru
    Oshima, Taito
    Hayashi, Toshiyuki
    Koba, Shinji
    Ohta, Motoko
    Satoh, Noriyuki
    Ito, Yasuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (05) : 762 - 774